Stay updated with breaking news from Adjuvant Setting. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Longer-term results from the OlympiA trial show a 32% improvement in overall survival with olaparib among women with early-stage germline BRCA-mutated breast cancer.
KEYTRUDA Is Now Approved as Monotherapy for Adults With RCC at Increased Risk of Recurrence Following Nephrectomy, or Following Nephrectomy and Resection of Metastatic Lesions KEYTRUDA Is the First
A blood test that measures circulating tumor DNA can identify patients with colorectal cancer who may derive the most benefit from adjuvant chemotherapy.
Comparable progression-free survival was observed in intermediate-risk patients with HPV and oropharynx cancer who received less intense postoperative radiation therapy, without chemotherapy.
Although dopamine agonists and dopamine reuptake inhibitors (DRIs) may be effective in treating Parkinson's disease and motor fluctuations not controlled with levodopa, not all DRIs are equal.